Healthcare provider profile · identity verified

Kavitha Thukkaram, M.D

Internal Medicine · METUCHEN, NJ · NPI 1003854282

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	757	124
Amlodipine Besylate	Amlodipine Besylate	515	87
Eliquis	Apixaban	505	44
Levothyroxine Sodium	Levothyroxine Sodium	423	62
Gabapentin	Gabapentin	294	46
Furosemide	Furosemide	290	51
Metformin Hcl	Metformin Hcl	286	47
Losartan Potassium	Losartan Potassium	248	46
Metoprolol Succinate	Metoprolol Succinate	229	42
Potassium Chloride	Potassium Chloride	210	31
Tamsulosin Hcl	Tamsulosin Hcl	192	31
Jardiance	Empagliflozin	181	20
Pantoprazole Sodium	Pantoprazole Sodium	153	37
Metoprolol Tartrate	Metoprolol Tartrate	149	26
Lisinopril	Lisinopril	146	21
Clopidogrel	Clopidogrel Bisulfate	144	20
Trazodone Hcl	Trazodone Hcl	143	26
Escitalopram Oxalate	Escitalopram Oxalate	131	23
Famotidine	Famotidine	127	37
Mirtazapine	Mirtazapine	126	27
Levetiracetam	Levetiracetam	119	12
Rosuvastatin Calcium	Rosuvastatin Calcium	114	25
Carvedilol	Carvedilol	113	24
Olmesartan Medoxomil	Olmesartan Medoxomil	98	25
Januvia	Sitagliptin Phosphate	96	12
Tradjenta	Linagliptin	96	suppressed
Alendronate Sodium	Alendronate Sodium	93	12
Memantine Hcl	Memantine Hcl	93	13
Midodrine Hcl	Midodrine Hcl	92	21
Allopurinol	Allopurinol	91	12
Lactulose	Lactulose	89	23
Simvastatin	Simvastatin	89	15
Donepezil Hcl	Donepezil Hcl	88	14
Hydralazine Hcl	Hydralazine Hcl	85	13
Montelukast Sodium	Montelukast Sodium	79	11
Pravastatin Sodium	Pravastatin Sodium	77	11
Lantus	Insulin Glargine,hum.Rec.Anlog	72	18
Carbidopa-Levodopa	Carbidopa/Levodopa	70	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	63	suppressed
Finasteride	Finasteride	63	suppressed
Sertraline Hcl	Sertraline Hcl	61	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Spironolactone	Spironolactone	55	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	54	21
Ramipril	Ramipril	54	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	11
Chlorthalidone	Chlorthalidone	50	suppressed
Latanoprost	Latanoprost	50	suppressed
Valsartan	Valsartan	50	suppressed
Divalproex Sodium	Divalproex Sodium	49	11
Xarelto	Rivaroxaban	48	suppressed
Celecoxib	Celecoxib	46	24
Hydrochlorothiazide	Hydrochlorothiazide	46	suppressed
Farxiga	Dapagliflozin Propanediol	45	suppressed
Warfarin Sodium	Warfarin Sodium	43	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	39	21
Trulicity	Dulaglutide	39	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	38	suppressed
Ibandronate Sodium	Ibandronate Sodium	37	suppressed
Budesonide	Budesonide	36	16
Quetiapine Fumarate	Quetiapine Fumarate	34	11
Albuterol Sulfate Hfa	Albuterol Sulfate	33	15
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Verapamil Hcl	Verapamil Hcl	33	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Entresto	Sacubitril/Valsartan	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Nystatin	Nystatin	31	suppressed
Acarbose	Acarbose	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	29	suppressed
Ozempic	Semaglutide	29	suppressed
Insulin Lispro	Insulin Lispro	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	17
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	12
Brilinta	Ticagrelor	26	suppressed
Digoxin	Digoxin	26	suppressed
Retacrit	Epoetin Alfa-Epbx	26	suppressed
Clonidine	Clonidine	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	25	suppressed
Humalog	Insulin Lispro	24	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Ssd	Silver Sulfadiazine	24	13
Topiramate	Topiramate	24	suppressed
Veltassa	Patiromer Calcium Sorbitex	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	21	suppressed
Heparin Sodium	Heparin Sodium,porcine	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Omeprazole	Omeprazole	21	suppressed
Timolol Maleate	Timolol Maleate	21	suppressed
Ketoconazole	Ketoconazole	20	11
Baclofen	Baclofen	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Nuplazid	Pimavanserin Tartrate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sotalol	Sotalol Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Nystop	Nystatin	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Glipizide	Glipizide	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Risperidone	Risperidone	16	suppressed
Aptiom	Eslicarbazepine Acetate	15	suppressed
Entacapone	Entacapone	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Albuterol Sulfate	Albuterol Sulfate	14	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Wegovy	Semaglutide	14	suppressed
Acetylcysteine	Acetylcysteine	13	suppressed
Atenolol	Atenolol	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Indapamide	Indapamide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Primidone	Primidone	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Selegiline Hcl	Selegiline Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error